Celularity (CELU) Interest & Investment Income (2019 - 2021)
Celularity (CELU) posted quarterly Interest & Investment Income of $9175.0 for Q2 2021, down 98.16% year-over-year from $497975.0 in Q2 2020, and down 67.09% quarter-over-quarter from $27883.0 in Q1 2021.
Celularity (CELU) Interest & Investment Income (2019 - 2021) Analysis & Trends
Celularity (CELU) has reported Interest & Investment Income for 3 consecutive years, with $9175.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Interest & Investment Income fell 98.16% year-over-year to $9175.0; the TTM figure through Jun 2021 stood at $635762.0 (down 86.44% YoY), while the FY2019 annual figure was $3.8 million, changed N/A from the prior year.
- Interest & Investment Income declined to $9175.0 in Q2 2021 per CELU's latest filing, from $27883.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.7 million in Q3 2019 and bottomed at $9175.0 in Q2 2021.
- Historically, Interest & Investment Income has averaged $687281.0 across 3 years, with a median of $584984.0 in 2019.
- Annual changes were most pronounced in 2020 — Interest & Investment Income fell 25.9% — and 2021, when it slumped 98.16%.
- Celularity's Interest & Investment Income stood at $1.4 million in 2019, then slumped by 92.81% to $100729.0 in 2020, then slumped by 90.89% to $9175.0 in 2021.
- Business Quant data shows CELU's Interest & Investment Income at $9175.0 in Q2 2021, $27883.0 in Q1 2021, and $100729.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 9,175.00 |
| Mar 31, 2021 | 27,883.00 |
| Sep 30, 2020 | 100,729.00 |
| Jun 30, 2020 | 497,975.00 |
| Mar 31, 2020 | 1.11 Mn |
| Dec 31, 2019 | 1.40 Mn |
| Sep 30, 2019 | 1.68 Mn |
| Jun 30, 2019 | 671,993.00 |